Log in to save to my catalogue

MED12 is recurrently mutated in Middle Eastern colorectal cancer

MED12 is recurrently mutated in Middle Eastern colorectal cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5868237

MED12 is recurrently mutated in Middle Eastern colorectal cancer

About this item

Full title

MED12 is recurrently mutated in Middle Eastern colorectal cancer

Publisher

England: BMJ Publishing Group LTD

Journal title

Gut, 2018-04, Vol.67 (4), p.663-671

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

ObjectiveColorectal cancer (CRC) is a common cancer and a leading cause of cancer deaths. Previous studies have identified a number of key steps in the evolution of CRC but our knowledge of driver mutations in CRC remains incomplete. Recognising the potential of studying different human populations to reveal novel insights in disease pathogenesis,...

Alternative Titles

Full title

MED12 is recurrently mutated in Middle Eastern colorectal cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5868237

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5868237

Other Identifiers

ISSN

0017-5749

E-ISSN

1468-3288

DOI

10.1136/gutjnl-2016-313334

How to access this item